病毒性肝炎在全世界广泛流行,尤其是乙型病毒性肝炎,其中相当一部分人变为慢性活动型,而慢性活动性肝炎又与肝硬化及原发性肝癌有密切的关系。因此,各国学者对于慢性活动性肝炎(以下简称“慢活肝”)的治疗作了很多研究。经过多年实践,人们对慢活肝定义的看法达到基本一致。慢活肝可分为自身免疫性慢性活动性肝炎(即HBsAg阴性的慢活肝)及与乙型肝炎病毒有关的病毒性慢性活动性肝炎(即HBsAg阳性的慢活肝)。到目前为止,慢活肝的治疗仍是一个非常棘手的课题,尚无理 Viral hepatitis is widely prevalent in the world, especially hepatitis B, a considerable number of whom become chronic active type, while chronic active hepatitis is closely related to cirrhosis and primary liver cancer. Therefore, many scholars have done a lot of research on the treatment of chronic active hepatitis (hereinafter referred to as “slow living liver”). After many years of practice, people’s views on the definition of slow-moving liver have basically reached the same level. Slow living liver can be divided into autoimmune chronic active hepatitis (ie HBsAg-negative slow-living liver) and hepatitis B virus-associated chronic viral hepatitis (ie HBsAg-positive slow living liver). So far, the treatment of slow liver is still a very difficult issue, unreasonable